Cargando…
Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report: Erratum
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521951/ https://www.ncbi.nlm.nih.gov/pubmed/31305693 http://dx.doi.org/10.1097/MD.0000000000007644 |
_version_ | 1783252073115025408 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5521951 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-55219512017-07-31 Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report: Erratum Medicine (Baltimore) Erratum Wolters Kluwer Health 2017-07-21 /pmc/articles/PMC5521951/ /pubmed/31305693 http://dx.doi.org/10.1097/MD.0000000000007644 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | Erratum Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report: Erratum |
title | Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report: Erratum |
title_full | Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report: Erratum |
title_fullStr | Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report: Erratum |
title_full_unstemmed | Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report: Erratum |
title_short | Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report: Erratum |
title_sort | marked response to nab-paclitaxel in egfr mutated lung neuroendocrine carcinoma: a case report: erratum |
topic | Erratum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521951/ https://www.ncbi.nlm.nih.gov/pubmed/31305693 http://dx.doi.org/10.1097/MD.0000000000007644 |